2024 Q3 Form 10-Q Financial Statement
#000147793224005700 Filed on September 13, 2024
Income Statement
Concept | 2024 Q3 |
---|---|
Revenue | $0.00 |
YoY Change | |
Cost Of Revenue | |
YoY Change | |
Gross Profit | |
YoY Change | |
Gross Profit Margin | |
Selling, General & Admin | |
YoY Change | |
% of Gross Profit | |
Research & Development | |
YoY Change | |
% of Gross Profit | |
Depreciation & Amortization | |
YoY Change | |
% of Gross Profit | |
Operating Expenses | $2.675K |
YoY Change | -39.31% |
Operating Profit | -$2.675K |
YoY Change | -39.31% |
Interest Expense | |
YoY Change | |
% of Operating Profit | |
Other Income/Expense, Net | |
YoY Change | |
Pretax Income | |
YoY Change | |
Income Tax | |
% Of Pretax Income | |
Net Earnings | -$2.675K |
YoY Change | -39.31% |
Net Earnings / Revenue | |
Basic Earnings Per Share | |
Diluted Earnings Per Share | |
COMMON SHARES | |
Basic Shares Outstanding | 120.0M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2024 Q3 |
---|---|
SHORT-TERM ASSETS | |
Cash & Short-Term Investments | $0.00 |
YoY Change | |
Cash & Equivalents | $0.00 |
Short-Term Investments | |
Other Short-Term Assets | |
YoY Change | |
Inventory | |
Prepaid Expenses | |
Receivables | |
Other Receivables | |
Total Short-Term Assets | $0.00 |
YoY Change | |
LONG-TERM ASSETS | |
Property, Plant & Equipment | |
YoY Change | |
Goodwill | |
YoY Change | |
Intangibles | |
YoY Change | |
Long-Term Investments | |
YoY Change | |
Other Assets | |
YoY Change | |
Total Long-Term Assets | $0.00 |
YoY Change | |
TOTAL ASSETS | |
Total Short-Term Assets | $0.00 |
Total Long-Term Assets | $0.00 |
Total Assets | $0.00 |
YoY Change | |
SHORT-TERM LIABILITIES | |
YoY Change | |
Accounts Payable | $8.825K |
YoY Change | -7.16% |
Accrued Expenses | |
YoY Change | |
Deferred Revenue | |
YoY Change | |
Short-Term Debt | $143.9K |
YoY Change | 19.06% |
Long-Term Debt Due | |
YoY Change | |
Total Short-Term Liabilities | $152.7K |
YoY Change | 17.15% |
LONG-TERM LIABILITIES | |
Long-Term Debt | $0.00 |
YoY Change | |
Other Long-Term Liabilities | |
YoY Change | |
Total Long-Term Liabilities | $0.00 |
YoY Change | |
TOTAL LIABILITIES | |
Total Short-Term Liabilities | $152.7K |
Total Long-Term Liabilities | $0.00 |
Total Liabilities | $152.7K |
YoY Change | 17.15% |
SHAREHOLDERS EQUITY | |
Retained Earnings | -$212.7K |
YoY Change | 11.74% |
Common Stock | $120.0K |
YoY Change | 0.0% |
Preferred Stock | |
YoY Change | |
Treasury Stock (at cost) | |
YoY Change | |
Treasury Stock Shares | |
Shareholders Equity | -$152.7K |
YoY Change | |
Total Liabilities & Shareholders Equity | $0.00 |
YoY Change |
Cashflow Statement
Concept | 2024 Q3 |
---|---|
OPERATING ACTIVITIES | |
Net Income | -$2.675K |
YoY Change | -39.31% |
Depreciation, Depletion And Amortization | |
YoY Change | |
Cash From Operating Activities | -$2.750K |
YoY Change | -22.97% |
INVESTING ACTIVITIES | |
Capital Expenditures | |
YoY Change | |
Acquisitions | |
YoY Change | |
Other Investing Activities | |
YoY Change | |
Cash From Investing Activities | |
YoY Change | |
FINANCING ACTIVITIES | |
Cash Dividend Paid | |
YoY Change | |
Common Stock Issuance & Retirement, Net | |
YoY Change | |
Debt Paid & Issued, Net | |
YoY Change | |
Cash From Financing Activities | 2.750K |
YoY Change | -22.97% |
NET CHANGE | |
Cash From Operating Activities | -2.750K |
Cash From Investing Activities | |
Cash From Financing Activities | 2.750K |
Net Change In Cash | 0.000 |
YoY Change | |
FREE CASH FLOW | |
Cash From Operating Activities | -$2.750K |
Capital Expenditures | |
Free Cash Flow | |
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-18667 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-13979 | usd | |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2675 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4408 | usd |
CY2024Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2675 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-212693 | usd |
CY2024Q3 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
CY2023Q4 | us-gaap |
Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
|
0 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001544400 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--10-31 | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2024-07-31 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2024 | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
CY2023Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120000000 | shares |
CY2023Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
120000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
120000000 | shares |
CY2023Q4 | nftn |
Due To Related Party Current
DueToRelatedPartyCurrent
|
6744 | usd |
CY2023Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120000000 | shares |
CY2023Q3 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
120000000 | shares |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Entity File Number
EntityFileNumber
|
333-180164 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
NFiniTi inc. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
NV | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Pampana 18 | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
La Cruz, C.P. | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
63734 | ||
dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
La Cruz de Huanacaxtle | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Nayarit | ||
dei |
Entity Address Country
EntityAddressCountry
|
MX | ||
dei |
City Area Code
CityAreaCode
|
523 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
221984348 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2024Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
120000000 | shares |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2024Q3 | us-gaap |
Assets Current
AssetsCurrent
|
0 | usd |
CY2023Q4 | us-gaap |
Assets Current
AssetsCurrent
|
0 | usd |
CY2024Q3 | us-gaap |
Assets
Assets
|
0 | usd |
CY2023Q4 | us-gaap |
Assets
Assets
|
0 | usd |
CY2024Q3 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
8825 | usd |
CY2023Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
10357 | usd |
CY2024Q3 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
137124 | usd |
CY2023Q4 | us-gaap |
Loans Payable Current
LoansPayableCurrent
|
116925 | usd |
CY2024Q3 | us-gaap |
Other Loans Payable Current
OtherLoansPayableCurrent
|
6744 | usd |
CY2023Q4 | us-gaap |
Other Loans Payable Current
OtherLoansPayableCurrent
|
6744 | usd |
CY2024Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
152693 | usd |
CY2023Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
134026 | usd |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2024Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Value
CommonStockValue
|
120000 | usd |
CY2023Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
120000 | usd |
CY2024Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
-60000 | usd |
CY2023Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
-60000 | usd |
CY2024Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-212693 | usd |
CY2023Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-194026 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-152693 | usd |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-134026 | usd |
CY2024Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | usd |
CY2023Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
0 | usd |
CY2024Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
CY2023Q3 | us-gaap |
Revenues
Revenues
|
0 | usd |
us-gaap |
Revenues
Revenues
|
0 | usd | |
us-gaap |
Revenues
Revenues
|
0 | usd | |
CY2024Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
2675 | usd |
CY2023Q3 | us-gaap |
Professional Fees
ProfessionalFees
|
4408 | usd |
us-gaap |
Professional Fees
ProfessionalFees
|
18667 | usd | |
us-gaap |
Professional Fees
ProfessionalFees
|
13979 | usd | |
CY2024Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
2675 | usd |
CY2023Q3 | us-gaap |
Operating Expenses
OperatingExpenses
|
4408 | usd |
us-gaap |
Operating Expenses
OperatingExpenses
|
18667 | usd | |
us-gaap |
Operating Expenses
OperatingExpenses
|
13979 | usd | |
CY2024Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2675 | usd |
CY2023Q3 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-4408 | usd |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-18667 | usd | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-13979 | usd | |
CY2024Q3 | nftn |
Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
|
-0.00 | |
CY2023Q3 | nftn |
Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
|
-0.00 | |
nftn |
Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
|
-0.00 | ||
nftn |
Earnings Per Common Share Basic And Diluted
EarningsPerCommonShareBasicAndDiluted
|
-0.00 | ||
CY2024Q3 | nftn |
Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
|
120000000 | shares |
CY2023Q3 | nftn |
Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
|
120000000 | shares |
nftn |
Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
|
120000000 | shares | |
nftn |
Weighted Average Number Of Common Share Outstanding Basic And Diluted
WeightedAverageNumberOfCommonShareOutstandingBasicAndDiluted
|
120000000 | shares | |
CY2023Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-134026 | usd |
CY2024Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-11567 | usd |
CY2024Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-145593 | usd |
CY2024Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4425 | usd |
CY2024Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-150018 | usd |
CY2024Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-152693 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-116363 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-6198 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-122561 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-3373 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-125934 | usd |
CY2023Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4408 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-130342 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
-18667 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
-13979 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-1532 | usd | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-696 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-20199 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-14674 | usd | |
nftn |
Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
|
20199 | usd | |
nftn |
Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
|
14674 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
20199 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
14674 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
0 | usd | |
CY2023Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2024Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
0 | usd |
CY2024Q3 | nftn |
Working Capital Deficits
WorkingCapitalDeficits
|
-152693 | usd |
CY2023Q4 | nftn |
Working Capital Deficits
WorkingCapitalDeficits
|
-134026 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </p> | ||
us-gaap |
Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company records revenue on an accrual basis when all goods and services have been performed and delivered, the amounts are readily determinable, and collection is reasonably assured. The Company has not generated any revenue since its inception.</p> | ||
CY2024Q3 | nftn |
Due To Related Party Current
DueToRelatedPartyCurrent
|
6744 | usd |
nftn |
Proceeds From Loan Payable Shareholders
ProceedsFromLoanPayableShareholders
|
20199 | usd | |
CY2024Q3 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
450000000 | shares |
CY2024Q3 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
120000000 | shares |